Most lately, it's been recognized that conolidine and the above derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to a big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts to be a scavenger https://chrisk653jln4.blogvivi.com/profile